ASCT Viewpoint
Apr. 24, 2013

Study: HPV vaccination sends genital wart cases plummeting
HealthDay News
In the five years since launching a nationwide human papillomavirus vaccination program among girls between the ages of 12 and 26, Australia has seen a huge drop in the number of cases of genital warts, new research reveals. Among Australian girls in the targeted age range for vaccination, the country saw genital wart cases plummet by 59 percent within just the first two years of the program's launch in 2007.More

The American Society for Cytotechnology celebrates National Medical Laboratory Professionals Week
April 22-26
American Society for Cytotechnology

Medical Laboratory Professionals Week is an annual celebration of all laboratory personnel who play a critical role in every aspect of health care. Lab Week is the perfect time to honor the more than 300,000 medical laboratory professionals who work behind the scenes performing and interpreting more than 10 billion laboratory tests in the U.S. per year. ASCT is proud to be one of 14 organizations that sponsor this important week in giving thanks to all laboratory professionals for their dedication to quality patient care.

HPV vaccination to provide even more protection in future against infections
Medical University of Vienna via Medical Xpress
The human papillomavirus vaccinations currently in use provide protection from 70 percent of the more than 100 strains of HPV, 14 of which can trigger cancers. The next vaccine generation is currently undergoing clinical trials at the MedUni Vienna and should be available in approximately two years' time.More

Cervical cancer screening software wins wireless competition
Medical Xpress
A software program for screening for cervical cancer, particularly in developing countries with limited resources, earned the top award and $10,000 in the Qualcomm Wireless Innovation Prize at UW-Madison. The AlgoCerv software enables people with limited medical training to scan Pap smear slides and provide results to a patient before she leaves the clinic.More

Study: Uterine cancer ties to later colon cancer
Depending on their age, women diagnosed with uterine cancer may have a higher risk of developing colon cancer later on, according to a new study from Canada. "As the survival has increased among cancer survivors, it's important to know what the other problems they're facing," said Dr. Harminder Singh, the study's lead author from the University of Manitoba in Winnipeg. More

How social networks influence parents' decision to vaccinate
With so much confusing and even misleading information about vaccine safety available on the Internet, it's no surprise that parents are influenced by their friends' attitudes when it comes to immunizing their kids. Researchers who surveyed 196 parents of children 18 months or younger in areas in Washington, Vermont, Wisconsin and Minnesota found at least 95 percent of parents in two groups indicated that they had consulted their "people network" for insight into making vaccination decisions.More

Can human genes be patented? High court weighs genetic test
NBC News
Can a company own a patent on the genes in the human body — including yours? The U.S. Supreme Court takes up that question, diving into an issue that could help determine the future of life-saving genetic medicine. The case involves a test that has helped guide more than a million women in their medical decisions. It can determine whether the composition of their genes makes them more likely to get breast or ovarian cancer.More

Media's role in cell culture success
Genetic Engineering & Biotechnology News
Many cell culture experts will argue that improvements in media and feed have been more responsible than any other factor in raising production titers for therapeutic proteins. While the "nature vs. nurture" argument is far from settled, culture media is at worst the partner of cell-line development in the quest for productivity, safety and efficacy.More

New method of growing laboratory cells could lead to safer drug trials
Researchers from the University of Southern Denmark have discovered a method that they claim will lead to safer, more accurate laboratory testing of novel drugs on humans. While cells occurring normally in a person's body are capable of exchanging vital information with one another, cells isolated for research purposes lose their ability to communicate, the investigators explain. However, because of this, those laboratory cells believe that they are alone and thus behave differently than they would if they were aware that they were surrounded by other cells. More

Study shows promise for uncovering mechanisms of human stem cell biology
The Medical News
For the first time, researchers at the University of North Carolina at Chapel Hill have isolated adult stem cells from human intestinal tissue. The accomplishment provides a much-needed resource for scientists eager to uncover the true mechanisms of human stem cell biology. It also enables them to explore new tactics to treat inflammatory bowel disease or to ameliorate the side effects of chemotherapy and radiation, which often damage the gut.More

UCLA study suggests potential therapy for HIV
Infection Control Today
UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection. Published in a recent edition of Science, the finding suggests new approaches to treating persistent viral infections like HIV and hepatitis C.More